Cited by 110Barrier Structure and Function StudiesDrug Transport and Resistance MechanismsNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 201 of the 203 references it cites were found in a registry or an index.

Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases

Anthony, Danielle Paige, Hegde, Manasa, Shetty, Shreya S., Rafic, Thasneema, Mutalik, Srinivas, Rao, B.S. Satish·2021·Life Sciences

DOI 10.1016/j.lfs.2021.119326

Open this paper in CoChat — free account

Abstract

The blood-brain barrier (BBB) is composed of a layer of endothelial cells that is interspersed with a series of tight junctions and characterized by the absence of fenestrations. The permeability of this barrier is controlled by junctions such as tight junctions and adherent junctions as well as several cells such as astrocytes, pericytes, vascular endothelial cells, neurons, microglia, and efflux transporters with relatively enhanced expression. It plays a major role in maintaining homeostasis in the brain and exerts a protective regulatory control on the influx and efflux of molecules. However, it proves to be a challenge for drug delivery strategies that target brain diseases like Dementia, Parkinson's Disease, Alzheimer's Disease, Brain Cancer or Stroke, Huntington's Disease, Lou Gehrig's Disease, etc. Conventional modes of drug delivery are invasive and have been known to contribute to a "leaky BBB", recent studies have highlighted the efficiency and relative safety of receptor-mediated drug delivery. Several receptors are exhibited on the BBB, and actively participate in nutrient uptake, and recognize specific ligands that modulate the process of endocytosis. The strategy employed in receptor-mediated drug delivery exploits this process of "tricking" the receptors into internalizing ligands that are conjugated to carrier systems like liposomes, nanoparticles, monoclonal antibodies, enzymes etc. These in turn are modified with drug molecules, therefore leading to delivery to desired target cells in brain tissue. This review comprehensively explores each of those receptors that can be modified to serve such purposes as well as the currently employed strategies that have led to increased cellular uptake and transport efficiency.

Integrity signals

Registry

Crossref · 10.1016/j.lfs.2021.119326

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
Ostrom, Q. T., Gittleman, H. R., Truitt, G., Boscia, A. L., Kruchko, C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,163
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C., Ferraro, G. B., & Jain, R. K. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,919
Targeted drug delivery via the folate receptor
Sudimack, J. J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,477
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,444
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbaşak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,442
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Blood–brain barrier delivery
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Astrocyte-endothelial Interactions and Blood-Brain Barrier Permeability*
Abbott, N. J. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00064.x · Cited by 1,168
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,038
Endocytic mechanisms for targeted drug delivery☆
Bareford, L. M., & Swaan, P. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,035
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 909
Functional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 829
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 724
Base excision repair of oxidative DNA damage and association with cancer and aging
Maynard, S., Schurman, S. H., Harboe, C., de Souza-Pinto, N. C., & Bohr, V. A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn250 · Cited by 712
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., van Oosten, M., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 666
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation
Luissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., & Couraud, P.-O. (2012) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-9-23 · Cited by 654
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 592
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Glial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 577
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
Wiley, D. T., Webster, P. C., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 535
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 507
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease
Cabezas, R., Ávila, M. F., González, J., El-Bachá, R. D. S., Báez-Jurado, E., García‐Segura, L. M., Jurado-Coronel, J. C., Capani, F., Cardona‐Gómez, G. P., & Barreto, G. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00211 · Cited by 481
Identification and Design of Peptides as a New Drug Delivery System for the Brain
Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., Castaigne, J., & Béliveau, R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131318 · Cited by 476
Getting into the Brain
Patel, B. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S., & Amin, A. F. (2008) · CNS Drugs · doi:10.2165/0023210-200923010-00003 · Cited by 466
Utilizing the folate receptor for active targeting of cancer nanotherapeutics
Zwicke, G. L., Ali Mansoori, G., & Jeffery, C. J. (2012) · Nano Reviews · doi:10.3402/nano.v3i0.18496 · Cited by 458
An update on the diagnosis and treatment of Parkinson disease
Rizek, P., Kumar, N., & Jog, M. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151179 · Cited by 455
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 454
Drug Targeting to the Brain
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 450
Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.017 · Cited by 443
Epidemiology of Brain Tumors
Ohgaki, H. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-492-0_14 · Cited by 423
Frontotemporal dementia
Olney, N. T., Spina, S., & Miller, B. L. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.008 · Cited by 419
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 405
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Lajoie, J. M., & Shusta, E. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124852 · Cited by 399
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399
Scavenger Receptor Structure and Function in Health and Disease
Abdul‐Zani, I., Stephen, S. L., Mughal, N. A., Russell, D., Homer‐Vanniasinkam, S., Wheatcroft, S. B., & Ponnambalam, S. (2015) · Cells · doi:10.3390/cells4020178 · Cited by 386
Dementia with Lewy bodies: an update and outlook
Outeiro, T. F., Koss, D. J., Erskine, D., Walker, L., Kurzawa-Akanbi, M., Burn, D., Donaghy, P., Morris, C., Taylor, J.-P., Thomas, A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0306-8 · Cited by 381
Folate-mediated targeting: from diagnostics to drug and gene delivery
Leamon, C. P., & Low, P. S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01594-4 · Cited by 377
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels.
Golden, P. L., Maccagnan, T. J., & Pardridge, W. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119125 · Cited by 372
Human blood-brain barrier transferrin receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1987) · Metabolism · doi:10.1016/0026-0495(87)90099-0 · Cited by 359
Drug Targeting to the Brain
de Boer, A. G., & Gaillard, P. J. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 355
Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
Hu, K., Li, J., Shen, Y., Lü, W., Gao, X., Zhang, Q., & Jiang, X. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor
Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 348
Current Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 347
Dementia
Duong, S., Patel, T., & Chang, F. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517690745 · Cited by 345
Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
Blasberg, R. G., Patlak, C. S., & Fenstermacher, J. D. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30311-3 · Cited by 341
Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
Fleisher, A., Raman, R., Siemers, E., Becerra, L. M., Clark, C. M., Dean, R. A., Farlow, M. R., Galvin, J. E., Peskind, E. R., Quinn, J. F., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1031 · Cited by 332
Drug treatment of epilepsy in adults
Schmidt, D., & Schachter, S. C. (2014) · BMJ · doi:10.1136/bmj.g254 · Cited by 327
Insulin-Binding Sites in the Rat Brain: In Vivo Localization to the Circumventricular Organs by Quantitative Radioautography*
van Houten, M., Posner, B. I., Kopriwa, B. M., & Brawer, J. R. (1979) · Endocrinology · doi:10.1210/endo-105-3-666 · Cited by 321
Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review
Braganza, M. Z., Kitahara, C. M., de González, A. B., Inskip, P. D., Johnson, K. J., & Rajaraman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos208 · Cited by 320
Strategies for transporting nanoparticles across the blood–brain barrier
Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Sánchez‐López, E., Ettcheto, M., Egea, M. A., Espina, M., Cano, A. C., Calpena, A. C., Camins, A., Carmona-Ule, N., Silva, A. M., Souto, E. B., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0356-z · Cited by 300
Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in Mouse
Lee, H., Engelhardt, B., Lesley, J., Bickel, U., & Pardridge, W. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35388-1 · Cited by 287
Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles
Liu, Y., Huang, R., Han, L., Ke, W., Shao, K., Ye, L., Lou, J., & Jiang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.051 · Cited by 285
Lewy Body Dementias
Gomperts, S. N. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000309 · Cited by 277
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease
Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 272
Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo.
Zitzmann, S., Ehemann, V., & Schwab, M. (2002) · PubMed · Cited by 265
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain
Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S. E., & Langer, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 263
Selection of phage‐displayed llama single‐domain antibodies that transmigrate across human blood‐brain barrier endothelium
Muruganandam, A., Tanha, J., Narang, S. A., & Stanimirovic, D. B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 261
Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)
Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259
Targeted delivery of proteins across the blood–brain barrier
Spencer, B. J., & Verma, I. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702170104 · Cited by 249
Targeted Molecular Therapy of GBM
Mischel, P. S., & Cloughesy, T. F. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00006.x · Cited by 247
Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells
Li, S., Amat, D., Peng, Z., Vanni, S., Raskin, S. I., Angulo, G. D., Othman, A. M., Graham, R. M., & Leblanc, R. M. (2016) · Nanoscale · doi:10.1039/c6nr05055g · Cited by 228
High transcytosis of melanotransferrin (P97) across the blood–brain barrier
Demeule, M., Poirier, J., Jodoin, J., Bertrand, Y., Desrosiers, R. R., Dagenais, C., Nguyen, T., Lanthier, J., Gabathuler, R., Kennard, M. L., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01201.x · Cited by 223
The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells
Abulrob, A., Sprong, H., Henegouwen, P. M. P. V. B. E., & Stanimirovic, D. B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03463.x · Cited by 223
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Dangouloff, T., & Servais, L. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s172291 · Cited by 211
Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor
Coloma, M. J., Lee, H., Kurihara, A., Landaw, E. M., Boado, R. J., Morrison, S. L., & Pardridge, W. M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007592720793 · Cited by 207
Decreased transport of leptin across the blood–brain barrier in rats lacking the short form of the leptin receptor☆
Kastin, A. J., Pan, W., Maness, L. M., Koletsky, R. J., & Ernsberger, P. R. (1999) · Peptides · doi:10.1016/s0196-9781(99)00156-4 · Cited by 207
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
Bi, C., Wang, A., Chu, Y., Liu, S., Mu, H., Liu, W., Wu, Z., Sun, K., & Li, Y. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s120939 · Cited by 203
Will the original glucose transporter isoform please stand up!
Carruthers, A., Zutter, J. K. D., Ganguly, A., & Devaskar, S. U. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2009 · Cited by 202
Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
Rao, A. M., & Hatcher, J. F. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784936608 · Cited by 201
Frontotemporal dementia: latest evidence and clinical implications
Young, J. J., Lavakumar, M., Tampi, D. J., Balachandran, S., & Tampi, R. R. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317739818 · Cited by 199
Temozolomide in malignant gliomas: current use and future targets
Villano, J. L., Seery, T. E., & Bressler, L. R. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1050-5 · Cited by 198
Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model
Lakkadwala, S., & Singh, J. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.047 · Cited by 194
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
Liu, Y., An, S., Li, J., Kuang, Y., He, X., Guo, Y., Ma, H., Zhang, Y., Ji, B., & Jiang, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.060 · Cited by 191
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain
van Rooy, I., Mastrobattista, E., Storm, G., Hennink, W. E., & Schiffelers, R. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.014 · Cited by 190
Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat
Cheng, D., Cao, N., Chen, J., Yu, X., & Shuai, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.057 · Cited by 184
Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review
Li, J., Zhao, J., Tan, T., Liu, M., Zeng, Z., Zeng, Y., Zhang, L., Fu, C., Chen, D., & Xie, T. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s243223 · Cited by 182
Site-Specific, Sustained Release of Drugs to the Brain
Bodor, N. S., Farag, H. H. A., & Brewster, M. E. (1981) · Science · doi:10.1126/science.7313698 · Cited by 181
A D ‐Peptide Ligand of Nicotine Acetylcholine Receptors for Brain‐Targeted Drug Delivery
Wei, X., Zhan, C., Shen, Q., Fu, W., Xie, C., Gao, J., Peng, C., Zheng, P., & Lu, W. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411226 · Cited by 181
Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 1)
Kusuhara, H., & Sugiyama, Y. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01632-9 · Cited by 177
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-β in Lewis rats
Yang, J.-S., Xu, L., Xiao, B., Hedlund, G., & Link, H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.016 · Cited by 175
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.015 · Cited by 174
Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).
Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172
Biopharmaceutical drug targeting to the brain
Pardridge, W. M. (2010) · Journal of drug targeting · doi:10.3109/10611860903548354 · Cited by 172
A leptin derived 30-amino-acid peptide modified pegylated poly-l-lysine dendrigraft for brain targeted gene delivery
Liu, Y., Li, J., Shao, K., Huang, R., Ye, L., Lou, J., & Jiang, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.011 · Cited by 172
Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial
Rajput, A. H., Martin, W. R. W., Saint‐Hilaire, M., Dorflinger, E. E., & Pedder, S. C. J. (1997) · Neurology · doi:10.1212/wnl.49.4.1066 · Cited by 168
Glial influences on BBB functions and molecular players in immune cell trafficking
Lécuyer, M., Kébir, H., & Prat, A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.004 · Cited by 166
Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Kumari, S., Saad, M. A., Kumar, J. M., Kondapi, A. K., & Rao, N. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06888-4 · Cited by 164
Herbal Drugs: Ethnomedicine to Modern Medicine
Ramawat, K. G. (2008) · Springer eBooks · doi:10.1007/978-3-540-79116-4 · Cited by 164
Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier
Pan, W., Kastin, A. J., Zankel, T. R., van Kerkhof, P., Terasaki, T., & Bu, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01381 · Cited by 159
Drug targeting with nanoparticles
Kreuter, J. (1994) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188928 · Cited by 153
Micelle‐Based Brain‐Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
Zhan, C., Li, B., Hu, L., Wei, X., Feng, L., Fu, W., & Lu, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100875 · Cited by 153
Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a
Tiwary, S., Morales, J. E., Kwiatkowski, S. C., Lang, F. F., Rao, G., & McCarty, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26636-6 · Cited by 153
Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
Pardridge, W. M. (2017) · BioDrugs · doi:10.1007/s40259-017-0248-z · Cited by 152
Mobile phone radiation causes brain tumors and should be classified as a probable human carcinogen (2A) (Review)
Morgan, L. L., Miller, A. B., Sasco, A. J., & Davis, D. L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2908 · Cited by 150
Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL‐associated vitamin E
Goti, D., Hrzenjak, A., Levak‐Frank, S., Frank, S., van der Westhuyzen, D. R., Malle, E., & Sattler, W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00100.x · Cited by 149
A brain targeting functionalized liposomes of the dopamine derivative N -3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease
Qu, M., Lin, Q., He, S., Wang, L., Fu, Y. S., Zhang, Z., & Zhang, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.019 · Cited by 139
Astrocytes Integrate Behavioral State and Vascular Signals during Functional Hyperemia
Tran, C. H. T., Peringod, G., & Gordon, G. R. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.045 · Cited by 135
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles
Wei, L., Guo, X., Yang, T., Yu, M., Chen, D., & Wang, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.127 · Cited by 133
Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon
Rajput, A. H., Martin, W. R. W., Saint‐Hilaire, M., Dorflinger, E. E., & Pedder, S. C. J. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s54 · Cited by 132
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 127
Efficacy of interleukin-13 receptor–targeted liposomal doxorubicin in the intracranial brain tumor model
Madhankumar, A. B., Slagle‐Webb, B., Wang, X., Yang, Q. X., Antonetti, D. A., Miller, P. A., Sheehan, J. M., & Connor, J. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0853 · Cited by 124
Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
Kwok, J. B. (2010) · Epigenomics · doi:10.2217/epi.10.43 · Cited by 124
Precision Nanomedicine in Neurodegenerative Diseases
Goldsmith, M., Abramovitz, L., & Peer, D. (2014) · ACS Nano · doi:10.1021/nn501292z · Cited by 124
Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations
Serwer, L., & James, C. D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.004 · Cited by 117
Correction: Corrigendum: The Phosphorylation Profile of Myosin Binding Protein-C Slow is Dynamically Regulated in Slow-Twitch Muscles in Health and Disease
Ackermann, M. A., Kerr, J. P., King, B., Ward, C. W., & Kontrogianni‐Konstantopoulos, A. (2018) · Scientific Reports · doi:10.1038/srep46969 · Cited by 116
Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
Zhan, C., Wei, X., Qian, J., Feng, L., Zhu, J., & Lu, W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.022 · Cited by 112
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data
Crouse, J. R., Byington, R. P., & Furberg, C. D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00014-8 · Cited by 111
Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor
Zhang, Y., & Pardridge, W. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082974 · Cited by 110
Therapeutic and Diagnostic Applications of Nanoparticles
Youns, M., Hoheisel, J. D., & Efferth, T. (2011) · Current Drug Targets · doi:10.2174/138945011794815257 · Cited by 107
Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine
Drion, N., Lemaire, M., Lefauconnier, J.-M., & Scherrmann, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041688.x · Cited by 104
A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration
Xu, X., Li, J., Han, S., Tao, C., Fang, L., Sun, Y., Zhu, J., Liang, Z., & Li, F. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.02.015 · Cited by 102
Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting
Feng, Q., Shen, Y., Fu, Y., Muroski, M. E., Zhang, P., Wang, Q., Xu, C., Lesniak, M. S., Li, G., & Cheng, Y. (2017) · Theranostics · doi:10.7150/thno.18985 · Cited by 99
Differential receptor-mediated drug targeting to the diseased brain
Rip, J., Schenk, G., & de Boer, A. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902806383 · Cited by 98
Designing the nanobiointerface of fluorescent nanodiamonds: highly selective targeting of glioma cancer cells
Šlegerová, J., Hajek, M., Řehoř, I., Sedlák, F., Štursa, J., Hrubý, M., & Cígler, P. (2014) · Nanoscale · doi:10.1039/c4nr02776k · Cited by 97
Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients
Chan, A., Weilbach, F. X., Toyka, K. V., & Gold, R. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02653.x · Cited by 97
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Juthani, R. G., Madajewski, B., Yoo, B., Zhang, L., Chen, P.-M., Chen, F., Turker, M. Z., Ma, K., Overholtzer, M., Longo, V. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1834 · Cited by 96
CA1-specific N -methyl- d -aspartate receptor knockout mice are deficient in solving a nonspatial transverse patterning task
Rondi‐Reig, L., Libbey, M., Eichenbaum, H., & Tonegawa, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041620798 · Cited by 92
Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review
Sheppard, J. P., Nguyen, T., Alkhalid, Y., Beckett, J. S., Salamon, N., & Yang, I. (2018) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2018.6.e4 · Cited by 90
The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier
Boado, R. J., & Pardridge, W. M. (2011) · Journal of Drug Delivery · doi:10.1155/2011/296151 · Cited by 83
Diphtheria toxin receptor-targeted brain drug delivery
Gaillard, P. J., Brink, A., & de Boer, A. G. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.022 · Cited by 83
Comparative Physiology of the Blood-Brain Barrier
Abbott, N. J. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-76894-1_15 · Cited by 83
In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
Candela, P., Saint‐Pol, J., Kuntz, M., Boucau, M., Lamartinière, Y., Gosselet, F., & Fénart, L. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.047 · Cited by 78
Modulation of transferrin receptor expression and function by anti-transferrin receptor antibodies and antibody fragments
Lesley, J., Schulte, R. J., & Woods, J. W. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90293-0 · Cited by 77
The ABC of the Blood-Brain Barrier - Regulation of Drug Efflux Pumps
Mahringer, A., Ott, M., Reimold, I., Reichel, V., & Fricker, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440221 · Cited by 72
Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo
Lakkadwala, S., Rodrigues, B. D. S., Sun, C., & Singh, J. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102112 · Cited by 72
Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases
Bélanger, K., Iqbal, U. H., Tanha, J., MacKenzie, R., Moreno, M., & Stanimirovic, D. B. (2019) · Antibodies · doi:10.3390/antib8020027 · Cited by 71
Loop 2 of Ophiophagus hannah Toxin b Binds with Neuronal Nicotinic Acetylcholine Receptors and Enhances Intracranial Drug Delivery
Zhan, C., Yan, Z., Xie, C., & Lu, W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100238j · Cited by 70
Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle
Peiris, P. M., Abramowski, A., Mcginnity, J., Doolittle, E., Toy, R., Gopalakrishnan, R., Shah, S., Bauer, L., Ghaghada, K. B., Hoimes, C. J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1540 · Cited by 69
Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo
Huang, R., Ke, W., Han, L., Liu, Y., Shao, K., Jiang, C., & Pei, Y. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.12.008 · Cited by 69
O2 exchange between blood and brain tissues studied with 18O2 indicator-dilution technique
Grieb, P., Forster, R. E., Strome, D. R., Goodwin, C. W., & Pape, P. C. (1985) · Journal of Applied Physiology · doi:10.1152/jappl.1985.58.6.1929 · Cited by 68
Brain Targeted Drug Delivery System
(2018) · Elsevier eBooks · doi:10.1016/c2017-0-00836-4 · Cited by 62
Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis
Tamaru, M., Akita, H., Fujiwara, T., Kajimoto, K., & Harashima, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.024 · Cited by 61
Solid lipid nanoparticles carrying chemotherapeutic drug across the blood–brain barrier through insulin receptor-mediated pathway
Kuo, Y., & Shih-Huang, C.-Y. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.812094 · Cited by 59
Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells
MacDonald, J. P., Denoyer, D., Henri, J., Jamieson, A., Burvenich, I. J. G., Pouliot, N., & Shigdar, S. L. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2019.0807 · Cited by 59
Immunocytochemical distribution of transferrin and its receptor in the developing chicken nervous system
Oh, T. H., Markelonis, G. J., ROYAL, G., & Bregman, B. S. (1986) · Developmental Brain Research · doi:10.1016/0165-3806(86)90111-2 · Cited by 58
Perspectives on brain-targeting drug delivery systems.
Guo, L., Ren, J., & Jiang, X. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112803341770 · Cited by 57
Synthetic Polymer Nanoparticles Functionalized with Different Ligands for Receptor-Mediated Transcytosis across the Blood–Brain Barrier
Lu, Q., Cai, X., Zhang, X., Li, S., Song, Y., Du, D., Dutta, P., & Lin, Y. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00502 · Cited by 55
Brain aging and Parkinson’s disease: New therapeutic approaches using drug delivery systems
Rodríguez‐Nogales, C., Garbayo, E., Carmona‐Abellán, M., Luquín, M. R., & Blanco‐Prieto, M. J. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.11.009 · Cited by 54
A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin
Prabhu, S., Goda, J. S., Mutalik, S., Mohanty, B. S., Chaudhari, P., Rai, S., Udupa, N., & Rao, B. S. S. (2017) · Nanoscale · doi:10.1039/c7nr00305f · Cited by 54
Self-citation
Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles
Chen, W., Zhan, C., Gu, B., Meng, Q., Wang, H., Lu, W., & Hou, H. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.492523 · Cited by 52
Can Leptin-Derived Sequence-Modified Nanoparticles Be Suitable Tools for Brain Delivery?
Tosi, G., Badiali, L., Ruozi, B., Vergoni, A. V., Bondioli, L., Ferrari, A., Rivasi, F., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.98 · Cited by 52
Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines
Tontini, M., Berti, F., Romano, M. R., Proietti, D., Zambonelli, C., Bottomley, M. J., Gregorio, E. D., Giudice, G. D., Rappuoli, R., Costantino, P., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.078 · Cited by 52
Clinical presentation and epidemiology of brain tumors firstly diagnosed in adults in the Emergency Department: a 10-year, single center retrospective study
Comelli, I., Lippi, G., Campana, V., Servadei, F., & Cervellin, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.12 · Cited by 52
Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere–cationic folate nanoconjugate
Elechalawar, C. K., Bhattacharya, D., Ahmed, M. T., Ravuri, H. G., Sridharan, K., Chaturbedy, P., Sinha, S. H., Jaggarapu, M. M. C. S., Narayan, K. P., Chakravarty, S., et al. (2019) · Nanoscale Advances · doi:10.1039/c9na00056a · Cited by 49
Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro
Wang, P., Xue, Y., Shang, X., & Liu, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9496-x · Cited by 49
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197):In VivoExperiments
Tosi, G., Vilella, A., Veratti, P., Belletti, D., Pederzoli, F., Ruozi, B., Vandelli, M. A., Zoli, M., & Forni, F. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00446 · Cited by 48
A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model
Thom, G., Tian, M.-M., Hatcher, J. P., Melero, N. R., Burrell, M. R., Gurrell, I. K., Vitalis, T. Z., Abraham, T., Jefferies, W. A., Webster, C. I., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18772998 · Cited by 47
Tumor cell targeted delivery by specific peptide-modified mesoporous silica nanoparticles
Wang, Y., Shi, W., Song, W., Wang, L., Liu, X., Chen, J., & Huang, R. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32398b · Cited by 46
Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood–brain barrier
Gabathuler, R., Arthur, G., Kennard, M. L., Chen, Q., Tsai, S., Yang, J., Schoorl, W., Vitalis, T., & Jefferies, W. A. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.021 · Cited by 46
Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage
Bouzinab, K., Summers, H. S., Stevens, M. F. G., Moody, C. J., Thomas, N. R., Gershkovich, P., Weston, N., Ashford, M. B., Bradshaw, T. D., & Turyanska, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01514 · Cited by 46
Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System
Kuplennik, N., Lang, K., Steinfeld, R., & Sosnik, A. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14659 · Cited by 45
Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis
Vinante, F., & Rigo, A. (2013) · Toxins · doi:10.3390/toxins5061180 · Cited by 44
Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor
Lentz, T. L. (1991) · Biochemistry · doi:10.1021/bi00109a020 · Cited by 41
Release characteristics of a short‐chain fatty acid, n‐butyric acid, from its β‐cyclodextrin ester conjugate in rat biological media
Hirayama, F., Ogata, T., Yano, H., Arima, H., Udo, K., Takano, M., & Uekama, K. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11 · Cited by 38
CRM197-Induced Blood–Brain Barrier Permeability Increase is Mediated by Upregulation of Caveolin-1 Protein
Wang, P., Liu, Y., Shang, X., & Xue, Y. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9471-5 · Cited by 35
Physiology of the Blood–Brain Barrier and Mechanisms of Transport Across the BBB
Lalatsa, A., & Butt, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00003-8 · Cited by 34
New non-oral drug delivery systems for Parkinson's disease treatment
Md, S., Haque, S., Sahni, J. K., Baboota, S., & Ali, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.556616 · Cited by 33
Phage display as a tool to discover blood–brain barrier ( BBB )‐shuttle peptides: panning against a human BBB cellular model
Díaz‐Perlas, C., Sánchez‐Navarro, M., Oller‐Salvia, B., Moreno, M. R., Teixidò, M., & Giralt, E. (2016) · Biopolymers · doi:10.1002/bip.22928 · Cited by 33
The Role of α1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis—Therapeutic Opportunities in Hemolytic Conditions
Kristiansson, A., Gram, M., Flygare, J., Hansson, S. R., Åkerström, B., & Storry, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197234 · Cited by 33
Drug treatment of Parkinson's disease
Korczyn, A. D. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.3/akorczyn · Cited by 31
The SR-B1 Receptor as a Potential Target for Treating Glioblastoma
Berney, E., Sabnis, N. A., Panchoo, M., Raut, S., Dickerman, R. D., & Lacko, A. G. (2019) · Journal of Oncology · doi:10.1155/2019/1805841 · Cited by 30
Duodopa pump treatment in patients with advanced Parkinson's disease.
Karlsborg, M., Korbo, L., Regeur, L., & Glad, A. (2010) · PubMed · Cited by 30
Nicotinic acetylcholine receptors
Wonnacott, S., Bermúdez, I., Millar, N. S., & Tzartos, S. J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14209 · Cited by 30
2B-Trans™ Technology: Targeted Drug Delivery Across the Blood-Brain Barrier
Gaillard, P. J., & de Boer, A. G. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-210-6_8 · Cited by 28
Overcoming the blood–brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system
Shi, W., Cui, X., Shi, J., Chen, J., & Wang, Y. (2017) · RSC Advances · doi:10.1039/c7ra03208k · Cited by 27
Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin
Sun, Z., Yan, X., Liu, Y., Huang, L., Kong, C., Qu, X., Wang, M., Gao, R., & Qin, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19221 · Cited by 27
Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma
Ji, X., Wang, H., Chen, Y., Zhou, J., & Liu, Y. (2019) · AMB Express · doi:10.1186/s13568-019-0869-3 · Cited by 25
Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity
Kuo, Y., & Liu, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.003 · Cited by 21
Insulin-coated gold nanoparticles as an effective approach for bypassing the blood-brain barrier
Betzer, O., Shilo, M., Motiei, M., & Popovtzer, R. (2019) · Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications · doi:10.1117/12.2510353 · Cited by 21
Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders
Mitra, S., Khatri, S. N., Maulik, M., Bult-Ito, A., & Schulte, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144918 · Cited by 21
Targeting the Inflammatory Response in Secondary Stroke Prevention: A Role for Combining Aspirin and Extended-release Dipyridamole
Weyrich, A. S., Skalabrin, E. J., & Kraiss, L. W. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31814b17bf · Cited by 18
Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain
Eiselt, É., Otis, V., Belleville, K., Yang, G., Larocque, A., Régina, A., Demeule, M., Sarret, P., & Gendron, L. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263566 · Cited by 18
Brain Drug Targeting: The Future of Brain Drug Development.: Pardridge W M. Cambridge University Press, 2001, 65.00. ISBN 0 521 80077 3
Kamphorst, W., de Boer, A. G., & Gaillard, P. J. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.2.158-a · Cited by 14
Receptor-mediated transportation through BBB
Zhang, Z., & Zhan, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00005-6 · Cited by 14
Novel Leads from Herbal Drugs for Neurodegenerative Diseases
Bhatnagar, M. (2008) · Springer eBooks · doi:10.1007/978-3-540-79116-4_14 · Cited by 12
Single domain antibodies as blood–brain barrier delivery vectors
Abulrob, A., Zhang, J., Tanha, J., MacKenzie, R., & Stanimirovic, D. B. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.024 · Cited by 12

Research works printed but not linked: 3

Chou, 2008, vol. 118, 17
Tsuji, 2000, Transporter-mediated permeation of drugs across the blood-brain barrier, J. Pharm. Sci., 89, 1371, 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D · DOI
Chen, 2012, Modern methods for delivery of drugs across the blood-brain barrier, Adv. Drug Deliv. Rev., 64, 640, 10.1016/j.addr.2011.11.010 · DOI

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“168 There have been a lot of studies undertaken using transferrin ligands.”
Background
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy
Achar, A., Westcott, R., & Ghosh, C. (2021) · Biomedicines · doi:10.3390/biomedicines9121834 · Cited by 203
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Mitusova, K. A., Peltek, O. O., Karpov, T. E., Muslimov, A. R., Zyuzin, M. V., & Timin, A. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01610-7 · Cited by 193
Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications
Truong, T. T., Mondal, S. A., Doan, V. H. M., Tak, S., Choi, J., Oh, H., Nguyen, T. D., Misra, M., Lee, B., & Oh, J. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103263 · Cited by 193

See all 110

Authors: Anthony, D. P., Hegde, M., Shetty, S. S., Rafic, T., Mutalik, S., & Rao, B. S. S.
Affiliations: Manipal Academy of Higher Education (IN)
Corresponding author: Rao, B.S. Satish
ORCID: Anthony, Danielle Paige
Rafic, Thasneema
Mutalik, Srinivas
Rao, B.S. Satish
Venue: Life Sciences
Publisher: Elsevier BV
Published: 2021-06
Volume: 274
Pages: 119326
ISSN: 0024-3205 (ISSN-L)
DOI: 10.1016/j.lfs.2021.119326
OpenAlex: W3135286150
Cited by: 110
References: 203
Citations by year: 2026: 10 · 2025: 30 · 2024: 31 · 2023: 16 · 2022: 18 · 2021: 5
FWCI: 2.05
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Life Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: blood-brain barrier, receptor-mediated drug delivery, tight junctions, endocytosis, liposomes, nanoparticles, monoclonal antibodies, brain disorders, Alzheimer's disease, Parkinson's disease, brain cancer, stroke, Huntington's disease, efflux pumps
MeSH terms: Animals, Biological Transport, Blood-Brain Barrier, Brain Diseases, Central Nervous System Agents, Drug Carriers, Humans, Ligands, Permeability, Receptors, Cell Surface, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks